Intellia Therapeutics Statistics
Total Valuation
NTLA has a market cap or net worth of $992.33 million. The enterprise value is $410.18 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NTLA has 103.58 million shares outstanding. The number of shares has increased by 11.19% in one year.
| Current Share Class | 103.58M |
| Shares Outstanding | 103.58M |
| Shares Change (YoY) | +11.19% |
| Shares Change (QoQ) | +1.62% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 92.59% |
| Float | 98.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.83 |
| Forward PS | 19.97 |
| PB Ratio | 1.19 |
| P/TBV Ratio | 1.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.90, with a Debt / Equity ratio of 0.15.
| Current Ratio | 4.90 |
| Quick Ratio | 4.57 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.92% and return on invested capital (ROIC) is -33.05%.
| Return on Equity (ROE) | -57.92% |
| Return on Assets (ROA) | -30.12% |
| Return on Invested Capital (ROIC) | -33.05% |
| Return on Capital Employed (ROCE) | -61.94% |
| Revenue Per Employee | $113,074 |
| Profits Per Employee | -$1.30M |
| Employee Count | 403 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.91% in the last 52 weeks. The beta is 2.13, so NTLA's price volatility has been higher than the market average.
| Beta (5Y) | 2.13 |
| 52-Week Price Change | -61.91% |
| 50-Day Moving Average | 8.12 |
| 200-Day Moving Average | 12.54 |
| Relative Strength Index (RSI) | 62.11 |
| Average Volume (20 Days) | 5,985,878 |
Short Selling Information
The latest short interest is 31.56 million, so 30.47% of the outstanding shares have been sold short.
| Short Interest | 31.56M |
| Short Previous Month | 30.70M |
| Short % of Shares Out | 30.47% |
| Short % of Float | 32.06% |
| Short Ratio (days to cover) | 6.56 |
Income Statement
In the last 12 months, NTLA had revenue of $45.57 million and -$525.91 million in losses. Loss per share was -$5.21.
| Revenue | 45.57M |
| Gross Profit | -417.32M |
| Operating Income | -541.07M |
| Pretax Income | -508.80M |
| Net Income | -525.91M |
| EBITDA | -530.80M |
| EBIT | -541.07M |
| Loss Per Share | -$5.21 |
Full Income StatementBalance Sheet
The company has $503.75 million in cash and $119.25 million in debt, giving a net cash position of $587.85 million or $5.68 per share.
| Cash & Cash Equivalents | 503.75M |
| Total Debt | 119.25M |
| Net Cash | 587.85M |
| Net Cash Per Share | $5.68 |
| Equity (Book Value) | 779.92M |
| Book Value Per Share | 7.53 |
| Working Capital | 438.80M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$377.15 million and capital expenditures -$4.01 million, giving a free cash flow of -$381.16 million.
| Operating Cash Flow | -377.15M |
| Capital Expenditures | -4.01M |
| Free Cash Flow | -381.16M |
| FCF Per Share | -$3.68 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,187.36% |
| Pretax Margin | -1,154.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NTLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.19% |
| Shareholder Yield | -11.19% |
| Earnings Yield | -52.70% |
| FCF Yield | -38.19% |
Dividend DetailsAnalyst Forecast
The average price target for NTLA is $36.60, which is 282.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $36.60 |
| Price Target Difference | 282.05% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 104.34% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NTLA has an Altman Z-Score of 0.79 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.79 |
| Piotroski F-Score | 2 |